DMSO Improves Motor Function and Survival in the Transgenic SOD1-G93AMouse Model of Amyotrophic Lateral Sclerosis
![]() |
Park, Kyung-Ho
(Department of Veterinary Pathology, College of Veterinary Medicine, Kyungpook National University)
Kim, Yeon-Gyeong (Naason Science, Inc.) Park, Hyun Woo (Naason Science, Inc.) Lee, Hee Young (Naason Science, Inc.) Lee, Jeong Hoon (Naason Science, Inc.) Patrick, Sweeney (Naason Science, Inc.) Park, Larry Chong (Naason Science, Inc.) Park, Jin-Kyu (Department of Veterinary Pathology, College of Veterinary Medicine, Kyungpook National University) |
1 | Sanmartin-Suarez, C., Soto-Otero, R., Sanchez-Sellero, I. and Mendez-Alvarez, E. Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants. 2011. J. Pharmacol. Toxicol. Methods 63, 209-215. DOI |
2 | Scott, S., Kranz, J. E., Cole, J., Lincecum, J. M., Thompson, K., Kelly, N., Bostrom, A., Theodoss, J., Al-Nakhala, B. M., Vieira, F. G., Ramasubbu, J. and Heywood, J. A. 2008. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph. Lateral Scler. 9, 4-15. DOI |
3 | Panganamala, R. V., Sharma, H. M., Heikkila, R. E., Geer, J. C. and Cornwell, D. G. 1976. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins 11, 599-607. DOI |
4 | Simmons, Z. 2015. Patient-perceived outcomes and quality of life in ALS. Neurotherapeutics 12, 394-402. DOI |
5 | Bond, L., Bernhardt, K., Madria, P., Sorrentino, K., Scelsi, H. and Mitchell, C. S. 2018. A metadata analysis of oxidative stress etiology in preclinical amyotrophic lateral sclerosis: benefits of antioxidant therapy. Front. Neurosci. 12, 10. |
6 | Ahmeti, K. B., Ajroud-Driss, S., Al-Chalabi, A., Andersen, P. M., Armstrong, J., Birve, A., Blauw, H. M., Brown, R. H., Bruijn, L., Chen, W., Chio, A., Comeau, M. C., Cronin, S., Diekstra, F. P., Soraya Gkazi, A., Glass, J. D., Grab, J. D., Groen, E. J., Haines, J. L., Hardiman, O., Heller, S., Huang, J., Hung. W. Y., ITALSGEN consortium, Jaworski, J. M., Jones, A., Khan, H., Landers, J. E., Langefeld, C. D., Leigh, P. N., Marion, M. C., McLaughlin, R. L., Meininger, V., Melki, J., Miller, J. W., Mora, G., Pericak-Vance, M. A., Rampersaud, E., Robberecht, W., Russell, L. P., Salachas, F., Saris, C. G., Shatunov, A., Shaw, C. E., Siddique, N., Siddique, T., Smith, B. N., Sufit, R., Topp, S., Traynor, B. J., Vance, C., van Damme, P., van den Berg, L. H., van Es, M. A., van Vught, P. W., Veldink, J. H., Yang, Y., Zheng, J. G. and ALSGEN Consortium. 2013. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol. Aging 34, 357.e7-19. DOI |
7 | Authier, N., Dupuis, E., Kwasiborski, A., Eschalier, A. and Coudore, F. 2002. Behavioural assessment of dimethylsulfoxide neurotoxicity in rats. Toxicol. Lett. 132, 117-121. DOI |
8 | Bardutzky, J., Meng, X., Bouley, J., Duong, R. Ratan, T. Q. and Fisher, M. 2005. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J. Cereb. Blood Flow Metab. 25, 968-977. DOI |
9 | Broadwell, R. D., Salcman, M. and Kaplan, R. S. 1982. Morphologic effect of dimethyl sulfoxide on the blood-brain barrier. Science 217, 164-166. DOI |
10 | Cetin, H., Beeson, D., Vincent. A. and Webster, R. 2020. The structure, function, and physiology of the fetal and adult acetylcholine receptor in muscle. Front. Mol. Neurosci. 13. |
11 | Ikeda, Y. and Long, D. M. 1990. Comparative effects of direct and indirect hydroxyl radical scavengers on traumatic brain oedema. Acta Neurochir. Suppl. 51, 74-76. |
12 | Chio, A., Hammond, E. R., Mora, G., Bonito, V. and Filippini, G. 2015. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 86, 38-44. DOI |
13 | Guo Y., Zhang, K., Wang, Q., Li, Z., Yin, Y., Xu, Q., Duan, W. and Li, C. 2011. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Brain Res. 1374, 110-115. DOI |
14 | Han, S., Choi, J. R., Shin, K. S. and Kang, S. J. 2012. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. Brain Res. 1483, 112-117. DOI |
15 | Kong, Q., Carothers, S., Chang, Y. and Lin, C-L. G. 2012. The importance of preclinical trial timing - a potential reason for the disconnect between mouse studies and human clinical trials in ALS. CNS Neurosci. Ther. 18, 791-793. DOI |
16 | Lou, J. S., Moore, D., Gordon, P. H. and Miller, R. 2010. Correlates of quality of life in ALS: Lessons from the minocycline study. Amyotroph. Lateral Scler. 11, 116-121. DOI |
17 | Nasrallah, F. A., Garner, B., Ball, G. E. and Rae, C. 2008. Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO). J. Neurosci. Res. 86, 208-214. DOI |
18 | Heitzer, M., Kaiser, S., Kanagaratnam, M., Zendedel, A., Hartmann, P., Beyer, C. and Johann, S. 2017. Administration of 17β-estradiol improves motoneuron survival and down-regulates inflammasome activation in male SOD1 (G93A) ALS mice. Mol. Neurobiol. 54, 8429-8443. DOI |
19 | Varma, R. K., Kaushal, R., Thomas, G. P., Junnarkar, A. Y., Singh, P. P. and Tripathi, R. M. 1987. Evaluation of dimethyl sulfoxide as a solvent in pharmacological experiments. Indian J. Exp. Biol. 25, 758-760. |
20 | Tintignac, L. A., Brenner, H. R. and Ruegg, M. A. 2015. Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol. Rev. 95, 809-852. DOI |
21 | Hartmaier, S. L., Rhodes, T., Cook, S. F., Schlusser, C., Chen, C., Han, S., Zach, N., Murthy V. and Dave, S. 2022. Qualitative measures that assess functional disability and quality of life in ALS. Health Qual. Life Outcomes 20, 12. |
22 | Goodall, E. F. and Morrison, K. E. 2006. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev. Mol. Med. 8, 1-22. DOI |
23 | Gurney, M. E., Fleck, T. J., Himes, C. S., Hall, E. D. 1998. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology 50, 62-66. DOI |
24 | Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H. X., Chen, W., Zhai, P., Sufit, R. L. and Siddique, T. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775. DOI |
25 | Hatzipetros, T., Kidd, J. D., Moreno, A. J., Thompson, K., Gill, A. and Vieira, F. G. 2015. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J. Vis. Exp. 104, e53257. DOI |
26 | Hensley, K., Mhatre, M., Mou, S., Pye, Q. N., Stewart, C., West, M. and Williamson, K. S. 2006. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox Signal. 8, 2075-2087. DOI |
27 | Zhang, X., Li, L., Chen, S., Yang, D., Wang, Y., Zhang, X., Wang, Z. and Le, W. 2011. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Autophagy 7, 412-425. DOI |
28 | Agar, J. and Durham, H. 2003. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph. Lateral Scler. 4, 232-242. |
29 | Huisman, M. H. B., de Jong, S. W., van Doormaal, P. T. C., Weinreich, S. S., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H. and van den Berg, L. H. 2011. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J. Neurol. Neurosurg. Psychiatry 82, 1165-1170. DOI |
30 | Jacob, S. W. and de la Torre, J. C. 2009. Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol. Rep. 61, 225-235. DOI |
31 | Zhang, X., Zhou, W. and Zhang, Y. 2018. Improvements in SOD mimic AEOL-10150, a potent broad-spectrum antioxidant. Mil. Med. Res. 5, 30. |
32 | Zhao, Z., Fu, J., Li, S. and Li. Z. 2019. Neuroprotective effects of genistein in a SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Neuroimmune Pharmacol. 14, 688-696. DOI |
33 | Yoo, Y. E. and Ko, C. P. 2011. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 231, 147-159. DOI |
34 | Zhang, J. J., Zhou, Q. M., Chen, S. and Le, W. D. 2018. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model. CNS Neurosci. Ther. 24, 1163-1174. DOI |
35 | Barber, S. C., Mead, R. J., Shaw and P. J. 2006. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta 1762, 1051-1067. DOI |
36 | Brink, J. J. and Stein, D. G. 1967. Pemoline levels in brain: enhancement by dimethyl sulfoxide. Science 158, 1479-1480. DOI |
37 | Blevins, J. E., Stanley, B. G. and Reidelberger, R. D. 2002. DMSO as a vehicle for central injections: tests with feeding elicited by norepinephrine injected into the paraventricular nucleus. Pharmacol. Biochem. Behav. 71, 277-282. DOI |
38 | Bonafede, R., Turano, E., Scambi, I., Busato, A., Bontempi, P., Virla, F., Schiaffino, L., Marzola, P., Bonetti, B. and Mariotti, R. 2020. ASC-exosomes ameliorate the disease progression in SOD1 (G93A) murine model underlining their potential therapeutic use in human ALS. Int. J. Mol. Sci. 21, 3651. |
39 | Borchelt, D. R., Lee, M. K., Slunt, H. S., Guarnieri, M., Xu, Z. S., Wong, P. C., Brown, R. H. Jr., Price, D. L., Sisodia, S. S. and Cleveland, D. W. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA. 91, 8292. |
40 | Budinich, C. S., Tucker, L. B., Lowe, D., Rosenberger, J. G. and McCabe, J. T. 2013. Short and long-term motor and behavioral effects of diazoxide and dimethyl sulfoxide administration in the mouse after traumatic brain injury. Pharmacol. Biochem. Behav. 108, 66-73. DOI |
41 | Cavaletti, G., Oggioni, N., Sala, F., Pezzoni, G., Cavalletti, E., Marmiroli, P., Petruccioli, M. G., Frattola, L. and Tredici, G. 2000. Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol. Lett. 118, 103-107. DOI |
42 | Colucci, M., Maione, F., Bonito, M. C., Piscopo, A., Di Giannuario, A. and Pieretti, S. 2008. New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation. Pharmacol. Res. 57, 419-425. DOI |
43 | Chang, C. K., Albarillo, M. V. and Schumer, W. 2001. Therapeutic effect of dimethyl sulfoxide on ICAM-1 gene expression and activation of NF-κB and AP-1 in septic rats. J. Surg. Res. 95, 181-187. DOI |
44 | Chiarotto, G. B., Cartarozzi, L. P., Perez, M., Biscola, N. P., Spejo, A. B., Gubert, F., Franca Junior, M., Mendez-Otero, R. and de Oliveira, A. L. R. 2019. Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS. J. Neuroinflammation 16, 218. |
45 | Chiu, A. Y., Zhai, P., Dal Canto, M. C., Peters, T. M., Kwon, Y. W., Prattis, S. M. and Gurney, M. E. 1995. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6, 349-362. DOI |
46 | Clark, J. A., Blizzard, C. A., Breslin, M. C., Yeaman, E. J., Lee, K. M., Chuckowree, J. A. and Dickson, T. C. 2018. Epothilone D accelerates disease progression in the SOD1G 93A mouse model of amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 44, 590-605. DOI |
47 | Clark, J. A., Southam, K. A., Blizzard, C. A., King, A. E. and Dickson, T. C. 2016. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J. Chem. Neuroanat. 76, 35-47. DOI |
48 | de la Torre, J. C. 1991. Synergic activity of combined prostacyclin: dimethyl sulfoxide in experimental brain ischemia. Can. J. Physiol. Pharmacol. 69, 191-198. DOI |
49 | di Giorgio, A. M., Hou, Y., Zhao, X., Zhang, B., Lyeth, B. G. and Russell, M. J. 2008. Dimethyl sulfoxide provides neuroprotection in a traumatic brain injury model. Restor. Neurol. Neurosci. 26, 501-507. |
50 | Deng, H. X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W. Y., Getzoff, E. D., Hu, P., Herzfeldt, B. and Roos, R. P. 1993. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047-1051. DOI |
51 | Dong, Q., Zhu. J., Liu, S., Yu, X. and Liu, R. 2018. An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS. Int. Immunopharmacol. 65, 413-421. DOI |
52 | Farkas, E., Institoris, A., Domoki, F., Mihaly, A., Luiten, P. G. M. and Bari, F. 2004. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res. 1008, 252-260. DOI |
53 | Fridovich, I. 1975. Superoxide dismutases. Annu. Rev. Biochem. 44, 147-159. DOI |
54 | Gibson, G. E., Zhang, H., Sheu, K. F. R. and Park, L. C. H. 2000. Differential alterations in antioxidant capacity in cells from Alzheimer patients. Biochim. Biophys. Acta 1502, 319-329. DOI |
55 | Morrice, J. R., Gregory-Evans, C. Y. and Shaw, C. A. 2018. Animal models of amyotrophic lateral sclerosis: a comparison of model validity. Neural Regen. Res. 13, 2050-2054. DOI |
56 | Mulder, D. W., Kurland, L. T., Offord, K. P. and Beard, C. M. 1986. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36, 511-517. DOI |
57 | Yim, M. B., Kang, J. H., Yim, H. S., Kwak, H. S., Chock, P. B. and Stadtman, E. R. 1996. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 93, 5709-5714. DOI |
58 | Nagano, S., Ogawa, Y., Yanagihara and T., Sakoda, S. 1999. Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci. Lett. 265, 159-162. DOI |
59 | Vinsant, S., Mansfield, C., Jimenez-Moreno, R., Moore, V. D. G., Yoshikawa, M., Hampton, T. G., Prevette, D., Caress, J., Oppenheim, R. W. and Milligan, C. 2013. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part I, background and methods. Brain Behav. 3, 335-350. DOI |
60 | Weishaupt, J. H., Bartels, C., Polking, E., Dietrich, J., Rohde, G., Poeggeler, B., Mertens, N., Sperling, S., Bohn, M., Huther, G., Schneider, A., Bach, A., Siren, A. L., Hardeland, R., Bahr, M., Nave, K. A. and Ehrenreich, H. 2006. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J. Pineal Res. 41, 313-323. DOI |
61 | Miquel, E., Cassina, A., Martinez-Palma, L., Souza, J. M., Bolatto, C., Rodriguez-Bottero, S., Logan, A., Smith, R. A. J., Murphy, M. P., Barbeito, L., Radi, R. and Cassina, P. 2014. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radic. Biol. Med. 70, 204-213. DOI |
62 | Jung, C., Rong, Y., Doctrow, S., Baudry, M., Malfroy, B. and Xu, Z. 2001. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci. Lett. 304, 157-160. DOI |
63 | Markvartova, V., Cendelin, J. and Vozeh, F. 2013. Effect of dimethyl sulfoxide in cerebellar mutant Lurcher mice. Neurosci. Lett. 543, 142-145. DOI |
64 | Lin, G. J., Wu, C. H., Yu, C. C., Lin, J. R., Liu, X. D., Chen, Y. W., Chang, H. M., Hong, Z. J., Cheng, C. P., Sytwu, H. K. and Huang, S. H. 2019. Adoptive transfer of DMSO-induced regulatory T cells exhibits a similar preventive effect compared to an in vivo DMSO treatment for chemical-induced experimental encapsulating peritoneal sclerosis in mice. Toxicol. Appl. Pharmacol. 378, 114641. |
65 | Liu, K. X., Edwards, B., Lee, S., Finelli, M. J., Davies, B., Davies, K. E. and Oliver, P. L. 2015. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. Brain 138, 1167-1181. DOI |
66 | Mahoney, D. J., Kaczor, J. J., Bourgeois, J., Yasuda, N. and Tarnopolsky, M. A. 2006. Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle Nerve 33, 809-816. DOI |
67 | Matias, M., Silvestre, S., Falcao, A. and Alves, G. 2018. Considerations and pitfalls in selecting the drug vehicles for evaluation of new drug candidates: focus on in vivo pharmaco-toxicological assays based on the rotarod performance test. J. Pharm. Pharm. Sci. 21, 110-118. DOI |
68 | Mead, R. J., Higginbottom, A., Allen, S. P., Kirby. J., Bennett, E., Barber, S. C., Heath, P. R., Coluccia, A., Patel, N., Gardner, I., Brancale, A., Grierson, A. J. and Shaw, P. J. 2013. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 61, 438-452. DOI |
69 | Petrov, D., Mansfield, C., Moussy, A. and Hermine, O. 2017. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front. Aging Neurosci. 9, 68. |
70 | Ohta, Y., Nomura, E., Shang, J., Feng, T., Huang, Y., Liu, X., Shi, X., Nakano, Y., Hishikawa, N., Sato, K., Takemoto, M., Yamashita and T. and Abe, K. 2019. Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis. J. Neurosci. Res. 97, 607-619. DOI |
71 | Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P. and Deng, H. X. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. DOI |
72 | Sala, G., Arosio, A., Conti, E., Beretta, S., Lunetta, C., Riva, N., Ferrarese and C., Tremolizzo, L. 2019. Riluzole selective antioxidant effects in cell models expressing amyotrophic lateral sclerosis endophenotypes. Clin. Psychopharmacol. Neurosci. 17, 438-442. DOI |
![]() |